Skip to main content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2006 | OriginalPaper | Hoofdstuk

Zijn bij gebruik van isoflavonen bij menopauzale klachten de risico’s op mammacacarcinoom vergroot?

Auteur : dr. L. Beex

Gepubliceerd in: Vademecum permanente nascholing huisartsen

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Natuurlijke of geïnduceerde uitval van de ovariële functie kan gepaard gaan met ernstige klachten.
Literatuur
go back to reference Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-27. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-27.
go back to reference Manson JAE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary Heart Disease. N Engl J Med 2003; 349:523-34. Manson JAE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary Heart Disease. N Engl J Med 2003; 349:523-34.
go back to reference Hilakivi-Clarke L, Trock B, Clarcke L. The estrogenicity of selected nutrients, phytochemicals, pesticides and pollutants. In: AM Bowcock Ed. Breast cancer: Molecular genetics, pathogenesis, and therapeutics. Human Press inc. Totowa, NJ, 1999: 537-48. Hilakivi-Clarke L, Trock B, Clarcke L. The estrogenicity of selected nutrients, phytochemicals, pesticides and pollutants. In: AM Bowcock Ed. Breast cancer: Molecular genetics, pathogenesis, and therapeutics. Human Press inc. Totowa, NJ, 1999: 537-48.
go back to reference Seidlova-Wuttke D, Hesse O, Jarry H, et al. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. Eur J Endocinol 2003; 149: 351-62. Seidlova-Wuttke D, Hesse O, Jarry H, et al. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. Eur J Endocinol 2003; 149: 351-62.
go back to reference Maskarinec G, Williams AE, Carlin L. Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev 2003; 12(2):165-69. Maskarinec G, Williams AE, Carlin L. Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev 2003; 12(2):165-69.
go back to reference Hargreaves DF, Potten CS, Harding C, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab. 1999; 84(11):4017-24. Hargreaves DF, Potten CS, Harding C, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab. 1999; 84(11):4017-24.
go back to reference Statistics from National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Database, 1994-97 Statistics from National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Database, 1994-97
go back to reference Peeters PHM, Keinan-Boker L, Schouw YT van der, Grobbee DE. Phytoestrogens and breast cancer risk. Breast Cancer Res Treat 2003; 77: 171-83. Peeters PHM, Keinan-Boker L, Schouw YT van der, Grobbee DE. Phytoestrogens and breast cancer risk. Breast Cancer Res Treat 2003; 77: 171-83.
go back to reference Tonkelaar I den, Keinan-Boker L, Veer P van ‘t, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer epidemiol Biomarkers Prev 2001; 10: 223-28. Tonkelaar I den, Keinan-Boker L, Veer P van ‘t, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer epidemiol Biomarkers Prev 2001; 10: 223-28.
go back to reference Tice JA, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 2003 9;290(2):207-14. Tice JA, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 2003 9;290(2):207-14.
go back to reference Upmalis DH, Rogerio L, Bradley L, et al. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double blind, randomised, placebo controlled study. Menopause 2000; 7: 236-42. Upmalis DH, Rogerio L, Bradley L, et al. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double blind, randomised, placebo controlled study. Menopause 2000; 7: 236-42.
go back to reference Davis SR. Phytoestrogen therapy for menopausal symptoms? There is no good evidence that it’s any better than placebo. Br Med J 2001; 323: 354-55. Davis SR. Phytoestrogen therapy for menopausal symptoms? There is no good evidence that it’s any better than placebo. Br Med J 2001; 323: 354-55.
go back to reference Loprinzi ChL, Barton DL, Rhodes D. Management of hot flushes in breast cancer survivors. The Lancet oncology 2001; 2: 199-204. Loprinzi ChL, Barton DL, Rhodes D. Management of hot flushes in breast cancer survivors. The Lancet oncology 2001; 2: 199-204.
go back to reference Pritchard KI. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives. Annals Oncol 2001; 12: 301-10. Pritchard KI. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives. Annals Oncol 2001; 12: 301-10.
Metagegevens
Titel
Zijn bij gebruik van isoflavonen bij menopauzale klachten de risico’s op mammacacarcinoom vergroot?
Auteur
dr. L. Beex
Copyright
2006
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8808-0_538